Medx Health Corp V.MDX

Alternate Symbol(s): MDXHF

Healthcare Medical Devices

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.

TSXV:MDX - Post by User

Medx Health Corp > BT Global Growth Monthly Report

<< Previous

Bullboard Posts

Next >>

Comment by Eastmkon Mar 06, 2021 8:45am

124 Views

Post# 32735668

RE:BT Global Growth Monthly Report

This has been my thinking all along. There is definitely a disconnect in the market that fails to recognize Medx's potential.

If you read through any of the marketing materials for DermTech, you will see that all of the facts in terms of the size of the melanoma detection market and the growth potential for for their technology is basically the same for Medx.

IMO a huge reason for the difference in share price is in the marketing and promotion of these two companies. DermTech has contracted The Motley Fool to promote their stock, meanwhile Medx has done a horrible job at getting the word out there.

The Medx website is so lacking that one cannot find the most basic information. Such as "How many melanomas has Medx technology detected to date?" A metric that could easily raise their profile amongst the investing public.

I hope this changes once they announce their "big deal" with Shopper's Drug Mart or the like that Mike has made appear so imminent during every interview during the last 6 months.